Bavarian Nordic (BVNRY) stock Forecast for 2022 – 2026
Last update: February 7, 2023 (06:17)Sector: Healthcare
The share price of Bavarian Nordic A/S (BVNRY) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For Bavarian Nordic stocks, the 50-day moving average is the support level today.
For Bavarian Nordic stocks, the 200-day moving average is the support level today.
Are you interested in Bavarian Nordic A/S stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Bavarian Nordic stock price in 2023, 2024, 2025, 2026, 2027. How much will one Bavarian Nordic share be worth in 2023 - 2027?
When should I take profit in Bavarian Nordic stock? When should I record a loss on Bavarian Nordic stock? What are analysts' forecasts for Bavarian Nordic stock? What is the future of Bavarian Nordic stock? We forecast Bavarian Nordic stock performance using neural networks based on historical data on Bavarian Nordic stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Bavarian Nordic stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Bavarian Nordic shares. This happens once a day.
Sell or Buy Bavarian Nordic (BVNRY) stocks? Analytic Experts Forecasting...
We present you the most up-to-date and complete review of analytical trend forecasts and views on the BVNRY stock market. … Read more
- Bavarian Nordic A/S Could Post A Strong Comeback
- Bavarian Nordic: A Stock You Should Not Miss In 2017
Historical and forecast chart of Bavarian Nordic stock
The chart below shows the historical price of Bavarian Nordic stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Bavarian Nordic stock price can be found in the table below.
Long-term forecasts by years.
Bavarian Nordic daily forecast for a month
Bavarian Nordic Daily Price Targets
Bavarian Nordic Stock Forecast 02-09-2023.
Forecast target price for 02-09-2023: $11.10.
Positive dynamics for Bavarian Nordic shares will prevail with possible volatility of 5.672%.
Pessimistic target level: 10.71
Optimistic target level: 11.35
Bavarian Nordic Stock Forecast 02-10-2023.
Forecast target price for 02-10-2023: $11.38.
Positive dynamics for Bavarian Nordic shares will prevail with possible volatility of 4.348%.
Pessimistic target level: 11.01
Optimistic target level: 11.51
Bavarian Nordic Stock Forecast 02-11-2023.
Forecast target price for 02-11-2023: $11.21.
Negative dynamics for Bavarian Nordic shares will prevail with possible volatility of 2.617%.
Pessimistic target level: 11.05
Optimistic target level: 11.35
Bavarian Nordic Stock Forecast 02-12-2023.
Forecast target price for 02-12-2023: $10.83.
Negative dynamics for Bavarian Nordic shares will prevail with possible volatility of 2.895%.
Pessimistic target level: 10.72
Optimistic target level: 11.04
Bavarian Nordic Stock Forecast 02-13-2023.
Forecast target price for 02-13-2023: $11.17.
Positive dynamics for Bavarian Nordic shares will prevail with possible volatility of 5.794%.
Pessimistic target level: 10.89
Optimistic target level: 11.56
Bavarian Nordic Stock Forecast 02-14-2023.
Forecast target price for 02-14-2023: $11.46.
Positive dynamics for Bavarian Nordic shares will prevail with possible volatility of 3.824%.
Pessimistic target level: 11.24
Optimistic target level: 11.69
BVNRY (BVNRY) Monthly Stock Prediction for 2023
Bavarian Nordic forecast for this year
Bavarian Nordic Stock Prediction for Mar 2023
An uptrend is forecast for this month with an optimal target price of $11.704. Pessimistic: $11.14. Optimistic: $12.20
Bavarian Nordic Stock Prediction for Apr 2023
An uptrend is forecast for this month with an optimal target price of $12.5701. Pessimistic: $12.07. Optimistic: $13.78
Bavarian Nordic Stock Prediction for May 2023
An uptrend is forecast for this month with an optimal target price of $13.0478. Pessimistic: $12.32. Optimistic: $13.80
Bavarian Nordic Stock Prediction for Jun 2023
An downtrend is forecast for this month with an optimal target price of $10.5426. Pessimistic: $9.28. Optimistic: $11.98
Bavarian Nordic Stock Prediction for Jul 2023
An uptrend is forecast for this month with an optimal target price of $10.5637. Pessimistic: $9.78. Optimistic: $11.77
Bavarian Nordic Stock Prediction for Aug 2023
An uptrend is forecast for this month with an optimal target price of $12.0848. Pessimistic: $10.15. Optimistic: $13.46
Bavarian Nordic Stock Prediction for Sep 2023
An uptrend is forecast for this month with an optimal target price of $12.1574. Pessimistic: $10.82. Optimistic: $14.05
Bavarian Nordic Stock Prediction for Oct 2023
An downtrend is forecast for this month with an optimal target price of $11.5738. Pessimistic: $10.58. Optimistic: $12.94
Bavarian Nordic Stock Prediction for Nov 2023
An downtrend is forecast for this month with an optimal target price of $10.671. Pessimistic: $9.63. Optimistic: $12.06
Bavarian Nordic Stock Prediction for Dec 2023
An downtrend is forecast for this month with an optimal target price of $10.1588. Pessimistic: $9.61. Optimistic: $10.79
Bavarian Nordic (BVNRY) Monthly Stock Prediction for 2024
Bavarian Nordic (BVNRY) Monthly Stock Prediction for 2025
Bavarian Nordic (BVNRY) Monthly Stock Prediction for 2026
Bavarian Nordic (BVNRY) Monthly Stock Prediction for 2027
Bavarian Nordic information and performance
Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer. Its products include IMVAMUNE for Ebola, HPV, HBV, and HIV diseases. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.